| 1 | 4-(4-(3,8-Diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol | MRTX1133 | 2621928-55-8 | 中间体- | |
| 2 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate | Regorafenib hydrate | 1019206-88-2 | 中间体- | |
| 3 | 氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯 | MLN4924 | 905579-51-3 | 中间体- | |
| 4 | 顺式-3-[8-氨基-1-(2-苯基-7-喹啉基)咪唑并[1,5-A]吡嗪-3-基]-1-甲基环丁醇 | OSI-906 (Linsitinib) | 867160-71-2 | 中间体- | |
| 5 | 劳拉替尼 | Lorlatinib (PF-06463922) | 1454846-35-5 | 中间体- | |
| 6 | BLU-945 | BLU-945 | 2660250-10-0 | 中间体- | |